Concepedia

Author

Kimio Ushijima

Kurume UniversityORCID

Also Known As

K USHIJIMA, K Ushijima, K. USHIJIMA, K. Ushijima, KIMIO USHIJIMA, Kimio USHIJIMA, Kimio Ushijima, Shin Nishio

310

Publications

5.1K

Citations

35

H-Index

116

Concepts

All Affiliations

Kurume UniversitySaitama Medical UniversityUniversity of TsukubaTohoku UniversityJikei University School of Medicine
KU

About

Kimio Ushijima is an author at Kurume University specializing in medicine, obstetrics, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

48

2.2K

2

Public Health

10

10

317

3

Health Sciences

3

3

97

4

Cell Biology

3

3

211

5

Allergy

1

1

11

Kimio Ushijima

×

91

Publications

4.6K

Citations

34

H-Index

YearCitations

Multicenter Phase II Study of Fertility-Sparing Treatment With Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young Women

Kimio Ushijima, Hideaki Yahata, Hiroyuki Yoshikawa,

Journal of Clinical Oncology

2007

407

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505

Ryo Kitagawa, Noriyuki Katsumata, Taro Shibata,

Journal of Clinical Oncology

2015

382

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602

Takashi Onda, Toyomi Satoh, Toshiaki Saito,

European Journal of Cancer

2016

246

Treatment for Recurrent Ovarian Cancer—At First Relapse

Kimio Ushijima

Journal of Oncology

2009

212

Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial

Takashi Onda, Toyomi Satoh, Gakuto Ogawa,

European Journal of Cancer

2020

207

High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway

Kosuke Yoshihara, Tatsuhiko Tsunoda, Daichi Shigemizu,

Clinical Cancer Research

2012

196

Analysis of gastric-type mucinous carcinoma of the uterine cervix — An aggressive tumor with a poor prognosis: A multi-institutional study

Shin Nishio, Yoshiki Mikami, Hideki Tokunaga,

Gynecologic Oncology

2019

156

Current status of gynecologic cancer in Japan

Kimio Ushijima

Journal of Gynecologic Oncology

2009

124

Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775

Vicky Makker, Nicoletta Colombo, Antonio Casado,

Journal of Clinical Oncology

2023

123

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma

Hiroaki Itamochi, Tetsuro Oishi, Nao Oumi,

British Journal of Cancer

2017

106

Page 1